In vitro Opposition binding studies verified that MAM-2201 and AM-2201 possess nanomolar affinity for equally CD-1 murine and human CB1 and CB2 receptors, with choice for the CB1 receptor. In arrangement Along with the in vitro binding knowledge, in vivo research showed that MAM-2201 induces Visible, acoustic, and tactile impairments https://jasonu505bpd7.wikijm.com/user